A combined omics approach to evaluate the effects of dietary curcumin on colon inflammation in the Mdr1a-/- mouse model of inflammatory bowel disease

Journal of Nutritional Biochemistry

Volumn 27, Issue , 2016, Pages 181-192

  Cooney, Janine M ^a   Barnett, Matthew P G ^a,b   Dommels, Yvonne E M ^c   Brewster, Diane ^e   Butts, Christine A ^c   McNabb, Warren C ^a,d   Laing, William A ^e   Roy, Nicole C ^a,b,d  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^b Food Nutrition and Health Team   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d AGRESEARCH GRASSLANDS   (New Zealand)

^e MASSEY UNIVERSITY   (New Zealand)

Author keywords

Alpha catenin; Curcuma longa; Extracellular matrix; Oligonucleotide array sequence analysis; Two dimensional difference gel electrophoresis

Indexed keywords

ALPHA CATENIN; CURCUMIN; FN1 PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEOME; TNFSF12 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DIET THERAPY; DOWN REGULATION; HISTOLOGICAL INJURY SCORE; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; MALE; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; SCORING SYSTEM; TRANSCRIPTOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; XENOBIOTIC METABOLISM; ANIMAL; COLITIS; DIET; DISEASE MODEL; GENETICS; MOLECULAR MODEL; PATHOLOGY;

ANIMALS; COLITIS; CURCUMIN; DIET; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; MICE; MODELS, MOLECULAR; P-GLYCOPROTEINS;

EID: 84952862240     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.08.030     Document Type: Article

References (60)

1. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
2. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753.
3. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998, 161:5733-5744.
4. Wilk J.N., Bilsborough J., Viney J.L. The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease. Immunol Res 2005, 31:151-159.
5. Dommels Y.E.M., Butts C., Zhu S.T., Davy M., Martell S., Hedderly D., et al. Characterization of inflammation in mdr1a-/- mice and identification of related gene expression changes in colonic epithelial cells. Genes Nutr 2007, 2:209-223.
6. Te Velde A.A., De Kort F., Sterrenburg E., Pronk I., Ten Kate F.J.W., Hommes D.W., et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:325-330.
7. Jagetia G.C., Aggarwal B.B. "Spicing up" of the immune system by curcumin. J Clin Immunol 2007, 27:19-35.
8. Taylor R.A., Leonard M.C. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev 2011, 16:152-156.
9. Shishodia S., Singh T., Chaturvedi M.M. Modulation of transcription factors by curcumin. The molecular targets and therapeutic uses of curcumin in health and disease 2007, 595:127-148. Springer, US.
10. Nones K., Dommels Y.E., Martell S., Butts C., McNabb W.C., Park Z.A., et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr 2009, 101:169-181.
11. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249.
12. Park E.I., Paisley E.A., Mangian H.J., Swartz D.A., Wu M.X., O'Morchoe P.J., et al. Lipid level and type alter stearoyl CoA desaturase mRNA abundance differently in mice with distinct susceptibilities to diet-influenced diseases. J Nutr 1997, 127:566-573.
13. Roy N.C., Barnett M.P.G., Knoch B., Dommels Y.E.M., McNabb W.C. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat Res 2007, 622:103-116.
14. Barnett M.P., Cooney J.M., Dommels Y.E., Nones K., Brewster D.T., Park Z., et al. Modulation of colonic inflammation in Mdr1a(-/-) mice by green tea polyphenols and their effects on the colon transcriptome and proteome. J Nutr Biochem 2013, 24:1678-1690.
15. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, S. Dudoit (Eds.).
16. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 1995, 57:289-300.
17. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210.
18. Knoch B., Barnett M.P., Cooney J., McNabb W.C., Barraclough D., Laing W., et al. Molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: a role for PPARalpha. PPAR Res 2010, 2010:621069.
19. Eng J.K., McCormack A.L., Yates J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5:976-989.
20. Yates J.R., Eng J.K., McCormack A.L., Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995, 67:1426-1436.
21. Kramer A., Green J., Pollard J., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 2014, 30:523-530.
22. Autschbach F., Giese T., Gassler N., Sido B., Heuschen G., Heuschen U., et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 2002, 441:500-513.
23. Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med 2010, 3:33-40.
24. Ohkawara T., Mitsuyama K., Takeda H., Asaka M., Fujiyama Y., Nishihira J. Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis. Scand J Gastroenterol 2008, 43:1497-1504.
25. Wang L., Srinivasan S., Theiss A.L., Merlin D., Sitaraman S.V. Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations. J Biol Chem 2007, 282:8219-8227.
26. Huveneers S., Oldenburg J., Spanjaard E., van der Krogt G., Grigoriev I., Akhmanova A., et al. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol 2012, 196:641-652.
27. DiNubile M.J. Plasma gelsolin as a biomarker of inflammation. Arthritis Res Ther 2008, 10:124.
28. Stossel T.P., Magnusson O.A.C., Tarkowski A. Use of gelsolin to diagnose and treat inflammatory diseases. Google Patents 2007.
29. Ślebioda T.J., Kmieć Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2014, 2014. 10.1155/2014/325129.
30. Broom O.J., Widjaya B., Troelsen J., Olsen J., Nielsen O.H. Mitogen activated protein kinases: a role in inflammatory bowel disease?. Clin Exp Immunol 2009, 158:272-280.
31. Anderson E.C., Wong M.H. Caught in the Akt: regulation of Wnt signaling in the intestine. Gastroenterology 2010, 139:718-722.
32. 2+ sensitization in murine experimental colitis. Mol Pharmacol 2009, 75:1031-1041.
33. Peng X.D., Wu X.H., Chen L.J., Wang Z.L., Hu X.H., Song L.F., et al. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice. J Pharmacol Exp Ther 2010, 332:46-56.
34. Shimshoni E., Yablecovitch D., Baram L., Dotan I., Sagi I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 2015, 64:367-372.
35. Brenmoehl J., Lang M., Hausmann M., Leeb S.N., Falk W., Scholmerich J., et al. Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa. Int J Colorectal Dis 2007, 22:611-623.
36. Kolachala V.L., Bajaj R., Wang L., Yan Y., Ritzenthaler J.D., Gewirtz A.T., et al. Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation. J Biol Chem 2007, 282:32965-32973.
37. Rieder F., Brenmoehl J., Leeb S., Scholmerich J., Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007, 56:130-139.
38. Vivinus-Nebot M., Frin-Mathy G., Bzioueche H., Dainese R., Bernard G., Anty R., et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014, 63:744-752.
39. Sakurai R., Li Y., Torday J.S., Rehan V.K. Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-beta signaling. Am J Physiol Lung Cell Mol Physiol 2011, 301:L721-L730.
40. Aravindan N., Madhusoodhanan R., Ahmad S., Johnson D., Herman T.S. Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 2008, 7:569-576.
41. Larmonier C.B., Midura-Kiela M.T., Ramalingam R., Laubitz D., Janikashvili N., Larmonier N., et al. Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis 2011, 17:503-515.
42. Baliga M.S., Joseph N., Venkataranganna M.V., Saxena A., Ponemone V., Fayad R. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Funct 2012, 3:1109-1117.
43. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009, 30:85-94.
44. Hatcher H., Planalp R., Cho J., Torti F.M., Torti S.V. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008, 65:1631-1652.
45. Epstein J., Docena G., MacDonald T.T., Sanderson I.R. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr 2010, 103:824-832.
46. Marathe S.A., Dasgupta I., Gnanadhas D.P., Chakravortty D. Multifaceted roles of curcumin: two sides of a coin!. Expert Opin Biol Ther 2011, 11:1485-1499.
47. Santos L.L., Fan H., Hall P., Ngo D., Mackay C.R., Fingerle-Rowson G., et al. Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice. Arthritis Rheum 2011, 63:960-970.
48. Song W.B., Wang Y.Y., Meng F.S., Zhang Q.H., Zeng J.Y., Xiao L.P., et al. Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation. PLoS One 2010, 5:e12969.
49. Ivanov A.I., Parkos C.A., Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 2010, 177:512-524.
50. Malik M., Mendoza M., Payson M., Catherino W.H. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil Steril 2009, 91:2177-2184.
51. Zheng S., Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 2006, 290:G883-G893.
52. Hajra K.M., Fearon E.R. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002, 34:255-268.
53. Sundram V., Chauhan S.C., Ebeling M., Jaggi M. Curcumin attenuates beta-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS One 2012, 7:e35368.
54. Midura-Kiela M.T., Radhakrishnan V.M., Larmonier C.B., Laubitz D., Ghishan F.K., Kiela P.R. Curcumin inhibits interferon-gamma signaling in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2012, 302:G85-G96.
55. Blasius R., Reuter S., Henry E., Dicato M., Diederich M. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. Biochem Pharmacol 2006, 72:1547-1554.
56. Kim H.Y., Park E.J., Joe E.H., Jou I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 2003, 171:6072-6079.
57. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol 2007, 5:3.
58. Irving G.R., Karmokar A., Berry D.P., Brown K., Steward W.P. Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 2011, 25:519-534.
59. Soni D., Salh B. A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer. Scientifica (Cairo) 2012, 2012:757890.
60. Yen F.L., Wu T.H., Tzeng C.W., Lin L.T., Lin C.C. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. J Agric Food Chem 2010, 58:7376-7382.